Comparative Pharmacology
Head-to-head clinical analysis: DEFERIPRONE versus FERRIPROX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEFERIPRONE versus FERRIPROX.
DEFERIPRONE vs FERRIPROX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Deferiprone is an iron chelator that binds to ferric iron (Fe3+) to form a stable complex, promoting iron excretion in urine. It reduces iron overload in tissues and prevents iron-induced free radical damage.
Deferiprone is an iron chelator that forms a stable complex with ferric iron (Fe3+), promoting its excretion primarily in urine. It reduces iron overload in tissues and prevents organ damage from excess iron.
75 mg/kg/day orally in three divided doses (maximum 3 g/day).
25 mg/kg orally three times daily, not to exceed 100 mg/kg/day.
None Documented
None Documented
2-3 hours (terminal elimination half-life). Due to its short half-life, multiple daily doses are required to maintain therapeutic chelation; levels decline rapidly after dose cessation.
Clinical Note
moderateMagnesium sulfate + Deferiprone
"The serum concentration of Deferiprone can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium salicylate + Deferiprone
"The serum concentration of Deferiprone can be decreased when it is combined with Magnesium salicylate."
Clinical Note
moderateIron sucrose + Deferiprone
"The serum concentration of Deferiprone can be decreased when it is combined with Iron sucrose."
Clinical Note
moderateIron + Deferiprone
Terminal elimination half-life is approximately 2.5 to 4 hours; clinical context: requires thrice-daily dosing to maintain therapeutic chelation
Primarily renal excretion as iron complex (ferrioxamine) and unchanged drug; 70-90% of a dose is recovered in urine within 24 hours, predominantly as the iron chelate. Less than 10% is eliminated in feces via biliary excretion.
Renal: approximately 85% as unchanged drug and metabolites (mainly glucuronide conjugate); fecal: <5%
Category C
Category C
Iron Chelator
Iron Chelator
"The serum concentration of Deferiprone can be decreased when it is combined with Iron."